0% found this document useful (0 votes)
48 views43 pages

Paeds Oncology

The document discusses common childhood malignancies, specifically Burkitt's Lymphoma, Nephroblastoma, and Neuroblastoma, outlining their definitions, classifications, risk factors, clinical presentations, and treatment options. It emphasizes the importance of early diagnosis and treatment for better prognosis, particularly in pediatric cases. The document also highlights the epidemiology and complications associated with these conditions.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
48 views43 pages

Paeds Oncology

The document discusses common childhood malignancies, specifically Burkitt's Lymphoma, Nephroblastoma, and Neuroblastoma, outlining their definitions, classifications, risk factors, clinical presentations, and treatment options. It emphasizes the importance of early diagnosis and treatment for better prognosis, particularly in pediatric cases. The document also highlights the epidemiology and complications associated with these conditions.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 43

PAEDIATRICS ONCOLOGY CONDITIONS

(CHILDHOOD MALIGNANCIES)
PYUZA,MD
1.Burkitt’s Lymphoma
2.Nephroblastoma
3.Neuroblastoma
Learning Objectives
By the end of the session, students are expected to be
able to:
• Define common childhood malignancies
• List the causes and risk factors for common
childhood malignancies
• Describe the clinical presentation of common
childhood malignancies
• List the treatment modalities for childhood
malignancies
BURKITT’S LYMPHOMA

3
Outline
• Definition
• Classification
• Aetiology/risk factors
• Epidemiology
• Clinical features
• Diagnosis
• DDx
• Complications
• Treatment
• Prognosis
4
Definition
• Burkitt’s Lymphoma (BL) is a highly
aggressive tumor of B-cell lymphocytes,
the lymphocytes that the immune
system uses to make antibodies.
• It is a non-Hodgkin Lymphoma (NHL)
• BL is extremely rapidly growing tumor
• It was first described in East Africa (Ug)
by Denis Parsons Burkitt in 1958.
5
Classification

• Burkitt’s Lymphoma can be classified as:


Endemic

Sporadic
Immunodeficiency-related Burkitt’s
lymphoma

6
Endemic BL

• It is common in Africa
• It is associated with the Epsten-Barr
Virus (EBV)
• Most commonly involves the jaw and
facial bone (orbit) in > 50% of cases.

7
Sporadic BL (Non-endemic)

• This is rare type seen all over the world

• No association with EBV


• Most often presents as abdominal
tumors with bone marrow involvement

8
Immunodeficiency-related Burkitt
lymphoma cases usually as with nodal
involvement with frequent bone marrow
involvement

9
Aetiology/Risk Factors

• The exact cause and mechanisms of


Burkitt’s lymphoma are not known

• Implicated factors include:-

– Chromosomal abnormalities:

– Viral infection: Epsten-Barr Virus (EBV)

– Malarial infection
10
Epidemiology
– Incidence in these areas of endemic
disease is 100 per million children.
– BL is a very rare tumor in the US, with
about 100 new cases occurring each
year.
– The male-to-female ratio is 2-3:1.
– BL is most common in children
– In Africa, the mean age is 7 years
11
Clinical features
• Jaw/facial swelling, rapidly growing (most
common)
– May involve orbit

• Abdominal masses, which can cause abdominal


pain, distention & ascites
– GI symptoms: Nausea, vomiting, loss of appetite,
change in bowel habits, features of acute abdomen
Intestinal perforation

12
• CNS involvement
– Meningeal infiltration, with or without
cranial nerve (CN) involvement (CN III and
CN VII); most common mode of
presentation with CNS disease
• Headaches
• visual impairment
• and paraplegia
These may be the initial presenting
features in some cases

13
• "B" systemic symptoms
– may be associated with other presenting
symptoms (eg, fever, weight loss, night
sweats, fatigue

• Other
– Bone marrow involvement
– Painless lymphadenopathy (adults >
children)

14
Stages of NHL
I Single tumor /node NOT in mediastinum
or abdomen
II 1-2 nodes same side of diaphragm or
resectable GI primary
III 2+ nodes both sides of diaphragm;
intrathoracic or extensive intra-abd
IV Any of above with CNS and/or BM

15
Diagnosis
• Biopsy of swelling to confirm the diagnosis.
• Abdominal pelvic US
• FBP
• Renal function test (Serum Creatinine & BUN)
• Serum electrolytes, calcium and phosphate
• Liver function test (Liver enzymes)
• HIV serology
• Peripheral smear
• Reticulocyte count
• LDH, Uric Acid 16
Differential Diagnosis

• Acute Lymphoblastic Leukemia (ALL)


• Other Lymphomas (eg.Diffuse Large Cell Lymphoma, Follicular,
Lymphoblastic, Mantle Cell Lymphoma)

• Neuroblastoma
• Wilms Tumor (Nephroblastoma)
• Ludwig angina
17
Complications
• Renal failure - as a result of retroperitoneal
disease and renal involvement.
• Gastrointestinal bleeding
• Acute abdomen
• Intestinal perforation

18
Treatment

• Chemotherapy

• Treatment of associated complications

19
Prognosis
• For children: early diagnosis and
treatment have good prognosis.

• Patients with bone marrow and CNS


involvement have a poor prognosis

• Adults especially those in the advanced


stage has poor prognosis.

20
NEPHROBLASTOMA
(Wilm’s Tumour)
Definition
Nephroblastoma (Wilm’s Tumor)
Is the cancer of the kidney(s) that typically
occurs in children.

– Is highly responsive to treatment, with about 90%


of patients surviving at least five years
Risk factors for Nephroblastoma
• People of African descent have the highest
rates of Wilm’s tumour.
• Females are more likely to develop the
tumour than males
• Most instances occur among children < 5
years
EPIDEMIOLOGY.
• The incidence of Wilms tumor is approximately 8 cases per
million children <15 yr of age.
• It usually occurs in children between 2–5 yr of age, although it
has also been encountered in neonates, adolescents, and
adults.
• It accounts for approximately 6% of pediatric cancers and is
the second most common malignant abdominal tumor in
childhood. It may arise in one or both kidneys; the incidence
of bilateral Wilms tumor is 7%.
• It may be associated with hemihypertrophy, aniridia, and
other congenital anomalies, usually of the genitourinary tract.
It also has been described in association with a variety of
syndromes
24
Clinical Presentation
• Common is abdominal swelling
or intraabdominal mass
(discovered by a parent while
bathing the child) that is
painless and lateralized to one
side deeply.
– Most are unilateral, bilateral
occurs in < 5% of cases
• Hematuria
• Hypertension (raised blood pressure)
• There may be
– Fever
– loss of appetite and weight loss

• Metastasis is usually to the lungs (respiratory


features)
• The rupture of the tumour puts the patient at
risk of haemorrhage and dissemination.
– Bleeding of the tumour can cause irritation in the
area of the kidney which may be painful
DIAGNOSIS
• HISTORY TAKING AND PHYSICAL EAXMINATION
• Any abdominal mass in a child must be considered malignant until
diagnostic imaging and laboratory findings define its true nature.
• If there is any doubt, biopsy or excision and histological verification
is the final arbiter. Wilms tumor must be differentiated from a
variety of malignant abdominal and pelvic tumors
• Once an abdominal mass is discovered, a complete physical
examination should be performed, followed by a complete blood
count, liver and kidney function studies, and a search for specific
tumor markers secreted by the suspected tumor.
• Imaging studies include a flat plate of the abdomen,
ultrasonography, and CT and/or MRI.

27
DDx
Management
• PRE REFERRAL MANAGEMANT.????????
• Refer the child to hospital without delay
• At the referral hospital
– Further investigation
– Management
• Surgery: Nephrectomy (partial or total)
• Chemotherapy
• Radiation
PROGNOSIS.

•There is remarkable correlation among the


DNA content in the cells of Wilms tumor,
histologic subtype, and treatment outcome.
•The prognosis is worse with a larger tumor
(>500 g), advanced stage (III and IV), and an
unfavorable histologic subtype.
•Wilms tumor is a paradigm of successful
multidisciplinary treatment, and >60% of
patients with all stages generally survive.
Stages I through III have a cure rate of >90%. 30
NEUROBLASTOMA
Definition
• Neuroblastoma is the Cancer of the
embryonal peripheral sympathetic nervous
system
• The most common extracranial solid tumour
in infancy
• Cause is unknown
– no specific environmental exposure or risk factors
have been identified
• EPIDEMILOGY
• Male-to-female ratio is 1.2 : 1

• 40% of patients are < 1 year old when


diagnosed
– incidence decreases every consecutive year up to
the age of 10 years, after which the disease is rare

• Age and stage are important prognostic


factors
RISK FACTORS

• The genetic event that initially triggers formation of NB is


not known.
• The pathogenesis is likely to be related to a succession of
mutational events, prenatally and perinatally, that may be
caused by environmental and genetic factors.
• Increased incidence of NB is associated with some maternal
and paternal occupational chemical exposures, work in
farming, and work related to electronics.
• Familial NB is found in 1–2% of cases. Neuroblastoma and
congenital cardiovascular malformations also may be
associated.
34
Clinical Presentation
• Signs and Symptoms (vary with site of
presentation e.g heart, blood vessels, bronchi, and GI tract)
• GI symptoms
– Abdominal pain
– Vomiting
– Weight loss
– Anorexia
– Fatigue

• If catecholamine producing tumor


– Sweating
– Hypertension (raised blood pressure)
– Profound diarrhea
• Redness of the eyes
(Racoon eyes) due to
metastatic disease to the
orbits
– Probably related to
obstruction of the palpebral
vessels {branches of the
ophthalmic and facial
vessels}
• Unexplained fever
• Irritability
• Approximately 2/3 of patients have
asymptomatic abdominal mass (usually
discovered by the parents)
• More than 50% of patients present with
advanced stage disease
– usually to the bone and bone marrow, thus bone
pain and a limp
• Metastatic lesions of the skin are common in
infants < 6 months
• Paraspinal dumbbell tumours can extend and
impinge on the spinal cord
– causing neurologic dysfunction (lower extremity
weakness or paraplegia)
DAGNOISIS
• HISTORY TAKING AND PHYSICAL EXAMINATION
• NB usually is discovered as a mass or multiple masses
on plain radiographs, CT, or MRI).
• Tumor markers, including homovanillic acid (HVA) and
vanillylmandelic acid (VMA) in urine, are elevated in
95% of cases and help to confirm the diagnosis.
• A pathologic diagnosis is established from tumor tissue
obtained by biopsy. NB can be diagnosed in a typical
presentation without a primary tumor biopsy if the
patient has neuroblasts observed in bone marrow and
elevated VMA or HVA in the urine.
39
DDx
• Esthesioneuroblastoma
• ganglioneuroblastoma
• pheochromocytoma
• Rhabdomyosarcoma
• Wilms' tumor
Management
• PRE REFELLAR MANAGEMENT??????
• Refer the child to hospital without delay
• At the referral hospital
– Chemotherapy
– Surgery
– Radiation
PREVENTION.

•Currently there is no recognized way to


prevent neuroblastoma. A worldwide attempt
to improve survival by early detection through
infant catecholamine screening has proven to
be ineffective

42
END
• THANK U

43

You might also like